ATLAS: High-risk RCC patients might benefit from adjuvant axitinibOctober 31, 2018Renal Cell CarcinomaGenitourinary Cancer
STAMPEDE: Radiation to prostate boosts survival of metastatic cancerOctober 22, 2018Genitourinary Cancer
Checkpoint inhibitor/TKI combo improves PFS of RCC over sunitinibOctober 22, 2018Renal Cell CarcinomaGenitourinary CancerImmuno-oncology
mRCC: Pazopanib appears safe in renal failureOctober 16, 2018Renal Cell CarcinomaGenitourinary Cancer
Moderate hypofractionation preferred in new guideline for localized PCOctober 15, 2018Genitourinary Cancer
No ADT-dementia link in large VA prostate cancer cohort studyOctober 15, 2018Genitourinary CancerPatient & Survivor CareRenal Cell Carcinoma
RCC incidence held steady through 2015 while mortality rates plummetedOctober 14, 2018Renal Cell CarcinomaGenitourinary Cancer
Primary, metastatic ccRCC share mutational featuresOctober 12, 2018Renal Cell CarcinomaGenitourinary Cancer
Updated analysis from JAVELIN Renal 101 to be presented at ESMO 2018October 11, 2018Renal Cell CarcinomaGenitourinary Cancer
Opioid use cut nearly 50% for urologic oncology surgery patientsOctober 5, 2018Patient & Survivor CareGenitourinary CancerOpioid Resource Center
Better therapy, not earlier diagnosis, explains improved RCC survivalOctober 2, 2018Renal Cell CarcinomaGenitourinary Cancer
Pazopanib is active against renal, other neoplasms of von Hippel-Lindau diseaseOctober 2, 2018Renal Cell CarcinomaGenitourinary Cancer
For solitary renal tumors, RFA looks good at 10 yearsOctober 1, 2018Renal Cell CarcinomaGenitourinary Cancer
